C.M. Rudin

机构：Memorial Sloan Kettering Cancer Center

发表论文 2 篇 · 总被引 38 次 · h-index 1

代表论文

• 441O Preliminary safety and clinical activity of erlotinib plus atezolizumab from a Phase Ib study in advanced NSCLC (2016 · Annals of Oncology · 被引 37)
• 161O RESILIENT part 2: A randomized, open-label phase III study of liposomal irinotecan versus topotecan in adults with relapsed small cell lung cancer (SCLC) (2023 · Journal of Thoracic Oncology · 被引 1)